The race to treat obesity with powerful new medicines has become one of the defining stories in global healthcare, and Novo ...

Novo Nordisk A/S secures FDA nod for oral Wegovy, expanding obesity treatment options. Click for how oral GLP-1 therapies ...

The pharmaceutical giant's stock has tumbled over the past year and a half, but it could be poised to storm back.

Since early August, the world’s most valuable pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), has put on a stellar ...

The magazine’s most-read articles of the year included a deep dive on the Scopes "monkey trial," an interview with ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The U.S. Food and Drug Administration’s ...

But Eli Lilly's Zepbound is best in class. Zepbound caused greater average weight loss than Wegovy in a head-to-head study. And through the first nine months of 2025, Zepbound generated $9.3 billion ...

Asian shares are mixed in thin holiday trading, with most markets in the region and elsewhere closed for Christmas ...

About 14% of adults in Philadelphia have diabetes, one of the highest rates in the country, the city said, and Black and ...

Wall Street closed higher and reached more records Wednesday on a holiday-shortened trading day. The Standard & Poor’s 500 index rose 22.26 points, or 0.3%, to 6,932.05. The Dow Jones industrial ...

Wall Street closed higher and reached more records Wednesday on a holiday-shortened trading day.The S&P 500 index rose 22.26 points, or<a class="excerpt-read-more" href=" More ...

NEW YORK — Wall Street slightly higher in midday trading Wednesday as markets hovered near record levels on a ...